Zhejiang Garden Bio-chemical High-tech Co Ltd (300401) - Total Assets

Latest as of September 2025: CN¥5.91 Billion CNY ≈ $865.31 Million USD

Based on the latest financial reports, Zhejiang Garden Bio-chemical High-tech Co Ltd (300401) holds total assets worth CN¥5.91 Billion CNY (≈ $865.31 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore debt repayment capacity of Zhejiang Garden Bio-chemical High-tech C to assess how comfortably operating cash covers total debt obligations.

Zhejiang Garden Bio-chemical High-tech Co Ltd - Total Assets Trend (2007–2024)

This chart illustrates how Zhejiang Garden Bio-chemical High-tech Co Ltd's total assets have evolved over time, based on quarterly financial data. See Zhejiang Garden Bio-chemical High-tech C book value and equity for net asset value and shareholders' equity analysis.

Zhejiang Garden Bio-chemical High-tech Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Zhejiang Garden Bio-chemical High-tech Co Ltd's total assets of CN¥5.91 Billion consist of 44.0% current assets and 56.0% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 22.9%
Accounts Receivable CN¥158.42 Million 2.8%
Inventory CN¥838.23 Million 14.9%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥209.25 Million 3.7%
Goodwill CN¥0.00 0.0%

Asset Composition Trend (2007–2024)

This chart illustrates how Zhejiang Garden Bio-chemical High-tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 300401 market cap.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Zhejiang Garden Bio-chemical High-tech Co Ltd's current assets represent 44.0% of total assets in 2024, a decrease from 61.0% in 2007.
  • Cash Position: Cash and equivalents constituted 22.9% of total assets in 2024, down from 46.6% in 2007.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 4.0% in 2007.
  • Asset Diversification: The largest asset category is inventory at 14.9% of total assets.

Zhejiang Garden Bio-chemical High-tech Co Ltd Competitors by Total Assets

Key competitors of Zhejiang Garden Bio-chemical High-tech Co Ltd based on total assets are shown below.

Company Country Total Assets
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
China CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
China CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
China CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
China CN¥925.41 Million
Jw Pharmac
KO:001060
Korea ₩605.27 Billion
Kamada
TA:KMDA
Israel ILA377.21 Million
Samjin Pharm
KO:005500
Korea ₩449.14 Billion

Zhejiang Garden Bio-chemical High-tech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.06 2.14 4.38
Quick Ratio 1.46 1.47 3.62
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥1.32 Billion CN¥1.33 Billion CN¥1.37 Billion

Zhejiang Garden Bio-chemical High-tech Co Ltd - Advanced Valuation Insights

This section examines the relationship between Zhejiang Garden Bio-chemical High-tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.71
Latest Market Cap to Assets Ratio 0.18
Asset Growth Rate (YoY) 6.7%
Total Assets CN¥5.61 Billion
Market Capitalization $998.06 Million USD

Valuation Analysis

Below Book Valuation: The market values Zhejiang Garden Bio-chemical High-tech Co Ltd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Zhejiang Garden Bio-chemical High-tech Co Ltd's assets grew by 6.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Zhejiang Garden Bio-chemical High-tech Co Ltd (2007–2024)

The table below shows the annual total assets of Zhejiang Garden Bio-chemical High-tech Co Ltd from 2007 to 2024.

Year Total Assets Change
2024-12-31 CN¥5.61 Billion
≈ $821.31 Million
+6.69%
2023-12-31 CN¥5.26 Billion
≈ $769.79 Million
+27.32%
2022-12-31 CN¥4.13 Billion
≈ $604.62 Million
+17.21%
2021-12-31 CN¥3.53 Billion
≈ $515.86 Million
+2.92%
2020-12-31 CN¥3.43 Billion
≈ $501.21 Million
+64.70%
2019-12-31 CN¥2.08 Billion
≈ $304.31 Million
+26.32%
2018-12-31 CN¥1.65 Billion
≈ $240.90 Million
+18.03%
2017-12-31 CN¥1.39 Billion
≈ $204.11 Million
+59.02%
2016-12-31 CN¥877.15 Million
≈ $128.35 Million
+11.34%
2015-12-31 CN¥787.84 Million
≈ $115.29 Million
+4.32%
2014-12-31 CN¥755.24 Million
≈ $110.52 Million
+29.36%
2013-12-31 CN¥583.85 Million
≈ $85.44 Million
+7.31%
2012-12-31 CN¥544.10 Million
≈ $79.62 Million
+12.20%
2011-12-31 CN¥484.95 Million
≈ $70.96 Million
+25.02%
2009-12-31 CN¥387.88 Million
≈ $56.76 Million
-14.18%
2008-12-31 CN¥451.95 Million
≈ $66.13 Million
-6.74%
2007-12-31 CN¥484.61 Million
≈ $70.91 Million
--

About Zhejiang Garden Bio-chemical High-tech Co Ltd

SHE:300401 China Drug Manufacturers - Specialty & Generic
Market Cap
$998.06 Million
CN¥6.82 Billion CNY
Market Cap Rank
#8817 Global
#2105 in China
Share Price
CN¥12.55
Change (1 day)
+1.05%
52-Week Range
CN¥10.88 - CN¥22.51
All Time High
CN¥24.01
About

Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cho… Read more